
HHS Updates Security Risk Assessment Tool to Address Healthcare Risks
The U.S. Department of Health and Human Services (HHS) has released version 3.7 of its Security Risk Assessment (SRA) Tool, updating a resource widely used

The U.S. Department of Health and Human Services (HHS) has released version 3.7 of its Security Risk Assessment (SRA) Tool, updating a resource widely used

A Healthcare organization can have strong compliance policies and still miss an excluded individual. The weakness often sits in the screening process itself. Healthcare Sanction

A Healthcare Compliance Program Assessment shows whether a provider’s compliance program works beyond written policies. Reviewers examine governance, controls, training, reporting, monitoring, investigations, and corrective

A growing ransomware operation is putting hospitals, healthcare providers and other critical infrastructure organizations on alert after U.S. and international cybersecurity agencies warned about attacks

Corporate integrity agreement requirements can significantly affect how healthcare providers manage compliance after a settlement. A Corporate Integrity Agreement, or CIA, establishes specific obligations between

The Health Information Privacy Reform Act (HIPRA) is gaining momentum in Washington, with a bipartisan proposal aimed at closing one of the biggest gaps in

Audit Readiness Starts Long Before the Inspector Arrives Pharmaceutical compliance should never become a last-minute exercise before a regulatory inspection. Pharmaceutical Compliance Consulting helps organizations

Strong compliance practices are essential for pharmaceutical companies operating in a highly regulated industry. Pharmaceutical Regulatory Compliance supports organizations in maintaining product quality, meeting regulatory

The deadline moved. The cyber threat did not. Healthcare organizations expected a final HIPAA Security Rule Update during May 2026. Instead, the federal regulatory agenda

A pharmaceutical product can take years of research, testing, and investment before reaching patients. However, one compliance gap can delay approval, interrupt production, or create